Method for detecting CA6 virus with real-time fluorescent quantitative PCR

A real-time fluorescence quantitative and virus technology, applied in the direction of microbial measurement/testing, biochemical equipment and methods, etc., to achieve high specificity

Inactive Publication Date: 2014-10-15
SHANGHAI PUBLIC HEALTH CLINICAL CENT
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there have been several outbreaks of HFMD caused by CA6 around the world, but there are few reports on rapid and sensitive methods for specific detection of CA6, especially no specific real-time PCR (real-time PCR) detection Report on the method of CA6 virus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting CA6 virus with real-time fluorescent quantitative PCR
  • Method for detecting CA6 virus with real-time fluorescent quantitative PCR
  • Method for detecting CA6 virus with real-time fluorescent quantitative PCR

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of nucleic detection and relates to a method for detecting CA6 virus with real-time fluorescent quantitative PCR. According to the method, a specific primer and a Taqman probe are designed on the basis of a CA6VP1 sequence and are used for detecting the CA6 virus rapidly, specifically and high-efficiently. By means of the method, gene segment of CA6 can be stably and effectively amplified and a highest detection sensitivity can reach 10 copius / [mu]l. In addition, the method is high in specificity and no false positive result is detected. The method for detecting the CA6 is quick, sensitive and reliable, can be further used for laboratory detection of a large-scale sample and an epidemiological inspection operation of the CA6 and is helpful to early-stage quick diagnosis in clinical practice.

Description

technical field The invention belongs to the detection field and relates to a nucleic acid detection method, in particular to a method for real-time fluorescent quantitative PCR detection of CA6 virus. Background technique The prior art discloses that hand, foot and mouth disease (HFMD) is a common infectious disease caused by human enterovirus (HEV); statistics show that the disease can occur all year round, 5 From July to July is the high-incidence period, and it is more common in children under 5 years old. Most of them have mild clinical symptoms, mainly fever and rash or herpes on the hands, feet, mouth and other parts. A small number of patients may have aseptic meningitis, encephalitis, Inflammation, acute flaccid paralysis (AFP), neurogenic pulmonary edema, and myocarditis, etc., the disease progresses rapidly in some severely ill children and can lead to death. Since 1997, there have been several outbreaks of HFMD in Malaysia, Singapore, Australia, China and other ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/70C12Q1/68
CPCC12Q1/6851C12Q1/70C12Q2531/113C12Q2561/101C12Q2561/113
Inventor 胡芸文管文彩张晓玲宋志刚
Owner SHANGHAI PUBLIC HEALTH CLINICAL CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products